Astera Labs, Inc. ALAB
364.62
4.11
1.14%
as of 25 Sep
- Market cap
- $63.7B
- P/E
- 168×
Follow ALAB
Growth Flags
show if company had growth for consecutive years
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
P/E ratio |
126.99 | 0.00 | 0.00 | 0.00 |
P/S ratio |
32.47 | 43.87 | 19.89 | 19.89 |
P/FCF ratio |
98.25 | 169.73 | 0.00 | 0.00 |
P/Operating CF |
290.60 | 437.89 | 159.96 | 159.96 |
P/B ratio |
20.30 | 18.02 | 0.00 | 0.00 |
Price to Tangible BV |
20.59 | 18.02 | 0.00 | 0.00 |
EV/Sales |
31.08 | 41.56 | 18.60 | 18.60 |
EV/EBITDA |
153.75 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
82.98 | 120.51 | (169.39) | (169.39) |
EV/FCF |
94.03 | 160.80 | (139.17) | (139.17) |
Quick Ratio |
9.56 | 11.01 | 4.49 | 4.34 |
Current Ratio |
10.24 | 11.71 | 5.30 | 5.14 |
Net Debt/EBITDA |
(6.90) | 7.53 | 5.08 | 2.72 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.66 | 0.63 | 0.57 | 0.00 |
Operating CF/Net income |
1.46 | (1.64) | 0.48 | 0.62 |
Capex/Depreciation |
34.04 | 6.48 | (22.45) | (13.73) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| 18.82% | (19.24%) | 28.70% | 0.00% | |
| 16.95% | (13.34%) | (12.87%) | 0.00% | |
ROIC |
62.00% | (143.65%) | 0.00% | 0.00% |
Return on Tangible Assets |
16.59% | (8.67%) | (16.89%) | (34.43%) |
Average Days of Receivables |
35.62 | 35.75 | 26.27 | 48.99 |
Research and Development Expense of Revenue |
35.66% | 50.68% | 63.39% | 92.29% |
Selling, General and Administrative Expense of Revenue |
19.69% | 54.99% | 31.02% | 56.55% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
18.77% | 59.20% | 9.22% | 37.85% |
Graham Net Nets |
0.04 | 0.05 | (0.05) | (0.05) |
Graham Number |
15.54 | 0.00 | 6.47 | 0.00 |
Earnings Yield |
0.79% | (1.30%) | (1.14%) | (1.14%) |
Free Cash Flow Yield |
1.02% | 0.59% | (0.67%) | (0.67%) |
Revenue per Share |
5.12 | 3.02 | 3.12 | 2.34 |
Operating CF per Share |
1.92 | 1.04 | (0.34) | (1.05) |
Capex per Share |
(0.23) | (0.26) | (0.07) | (0.11) |
Free Cash Flow per Share |
1.69 | 0.78 | (0.42) | (1.16) |
Cash per Share |
7.14 | 6.97 | 4.02 | 4.77 |
Shareholders Equity per Share |
8.19 | 7.35 | (2.63) | (2.50) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
8.19 | 7.35 | (2.63) | (2.50) |
Free Cash Flow |
281.76 | 102.43 | (15.48) | (39.77) |
Working Capital |
1,228.99 | 926.44 | 150.73 | 165.92 |
Capital Expenditures |
(37.54) | (34.24) | (2.76) | (3.87) |
Net Current Asset Value |
1,193.84 | 923.27 | (108.19) | (91.02) |
EV/EBIT |
152.78 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.04 | 0.09 | 0.02 | 0.05 |
Net Profit Margin |
25.70% | (21.05%) | (22.68%) | (73.05%) |
Price to Operating Income |
159.63 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||
Depreciation/Fixed assets |
(0.01) | (0.15) | 0.03 | 0.08 |
Cash ROIC |
8.90% | 5.38% | (33.77%) | (50.64%) |
Accounts Receivable Turnover |
13.97 | 16.81 | 12.15 | 0.00 |
Accounts Payable Turnover |
5.98 | 5.63 | 4.33 | 0.00 |
Inventory Turnover |
4.06 | 2.78 | 1.36 | 0.00 |
Average Days of Payables |
74.60 | 104.98 | 64.31 | 177.32 |
Days of Inventory on Hand |
103.86 | 168.54 | 244.52 | 497.33 |
Average Receivables |
61.01 | 23.57 | 9.53 | — |
Average Payables |
34.64 | 16.63 | 8.32 | — |
Average Inventory |
51.10 | 33.66 | 26.48 | — |
Average Assets |
1,293.17 | 625.40 | 204.01 | — |
Average Common Equity |
1,164.22 | 433.55 | (91.50) | — |
Columns are period end dates